Activ8rlives News & Case Studies

 
Latest News from Activ8rlives

‘Aggressive’ blood pressure control helps beat dementia, study finds

New research supports the evidence that high blood pressure or hypertension, sometimes called the ‘silent killer’, is pointing to a lowered chance of developing mild cognitive impairment when they keep their blood pressure below 120mg. The author of the new research, Dr Walter Koroshetz, director of the National Institutes of Health’s (NIH) National Institute of […]

Posted on August 15, 2019

Asthma+me – the App being trialled to help children manage severe asthma

A new Asthma+me App is being trialled at Sheffield Children’s Hospital to help children manage their severe asthma. A partnership between Sheffield Children’s and technology company Aseptika, the innovative trial uses the newly developed Asthma+me App to help patient and parents better manage severe asthma outside of the hospital. The App allows the patient and/or […]

Posted on August 12, 2019

Asthma+me innovative technology-enabled solution for paediatric asthma is shortlisted for Best Technological Innovation: Digital

The Medtech Insight Awards 2019 have shortlisted Aseptika’s Asthma+me solution in the category of ‘Best Technological Innovation: Digital’. Asthma+me has been co-designed with a Paediatrician at an NHS Trust (UK) to support transition from treatment in a specialist paediatric clinics to community care, with the initial focus on meeting the needs of children aged 6-12 […]

Posted on August 9, 2019

Aseptika wins big at West Midlands healthcare innovation awards

Local Cambridgeshire healthcare company, Aseptika Ltd (Activ8rlives) has been awarded the Digital or Artificial Intelligence Innovation of the Year Award at the Meridian Awards – A Celebration of Innovation, for its ground-breaking Active+me patient activation programme. The Active+me programme combines group exercise classes, health coaching, peer support, PAM (Patient Activation Measure) monitoring, with Aseptika – […]

Posted on August 5, 2019

Novel medical-grade wearable patent granted to Aseptika for BuddyWOTCH

Aseptika Ltd announces that the European Patent Office has granted a patent for its medical-grade wearable, for use by patients with severe cardiovascular and respiratory diseases (EU patent number 3197354).

Posted on July 24, 2019

1 2 3 14

Latest Case Studies

Active+me

Active+me is a programme that combines group exercise classes, health coaching, peer support, PAM (Patient Activation Measure) monitoring and teaching patients how to use Aseptika – Activ8rlives self-care monitoring technology to track their health and wellbeing. The data can also be reviewed remotely by health and care professionals, helping to identify deterioration in conditions more quickly than traditional methods of support.

SwansFan Clocks up 11 Gold Medals Walking with Activ8rlives

Ron aged 86-years young has been walking with an Activ8rlives BuddyBand activity tracker (accelerometer) since early September 2013. He has recently been awarded his eleventh Gold Medal for walking at least 10,000 steps a day for 1,925 days, which equates to about 80+ minutes of walking for Ron on each of those days. In during […]

Living Life Our Way Blood Pressure Review

Having tried out the Activ8rlives Blood Pressure and Heartrate monitor I found it to be a handy device that is quick and easy to set up and simple to use. It is genuinely useful, and is especially good for adults who need to monitor their blood pressure regularly, perhaps due to a previous health condition.

Maggie Johnson – an activated cardiac patient

"It has made me feel much more secure about my health, I can print out the data and take it to the next doctor’s appointment instead of having to remember how I’ve been feeling, it’s all there in black and white. I am sure that doing this programme will keep us all going for a lot longer.”

Colin getting control of his life back

“I want to be at the centre of my recovery, not being told what to do by a doctor all of the time", Colin said, who is living with incurable cancer.

1 2 3 7